Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1111-1120 of 1,467) with videos related to

Pageof 147
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 19, 2006
Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescentsChristian J Hopfer, Susan E Young, Shaun Purcell, et al.
Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisR Knevel, M Schoels, T W J Huizinga, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target in systemic lupus erythematosus: where are we today?Marta Mosca, Dimitrios T Boumpas, Ian N Bruce, et al.
Annals of the Rheumatic Diseases|November 9, 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, et al.
Dalton Transactions (Cambridge, England : 2003)|March 10, 2012
Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4,5,6,7-tetrachlorobenzimidazole against antibiotic resistant bacteriaBrian D Wright, Parth N Shah, Lucas J McDonald, et al.
Annals of the Rheumatic Diseases|August 22, 2023
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, et al.
The Journal of Biological Chemistry|January 22, 2021
A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growthCinta M Papke, Kali A Smolen, Mark R Swingle, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexateJosef S Smolen, Désirée M van der Heijde, Edward C Keystone, et al.
Arthritis and Rheumatism|December 4, 2012
Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritisM Bonelli, E Ferner, L Göschl, et al.
Pageof 147

Showing results (1111-1120 of 1,467) with videos related to

Sort By:
Pageof 147
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 19, 2006
Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescentsChristian J Hopfer, Susan E Young, Shaun Purcell, et al.
Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritisR Knevel, M Schoels, T W J Huizinga, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target in systemic lupus erythematosus: where are we today?Marta Mosca, Dimitrios T Boumpas, Ian N Bruce, et al.
Annals of the Rheumatic Diseases|November 9, 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, et al.
Dalton Transactions (Cambridge, England : 2003)|March 10, 2012
Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4,5,6,7-tetrachlorobenzimidazole against antibiotic resistant bacteriaBrian D Wright, Parth N Shah, Lucas J McDonald, et al.
Annals of the Rheumatic Diseases|August 22, 2023
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, et al.
The Journal of Biological Chemistry|January 22, 2021
A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growthCinta M Papke, Kali A Smolen, Mark R Swingle, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexateJosef S Smolen, Désirée M van der Heijde, Edward C Keystone, et al.
Arthritis and Rheumatism|December 4, 2012
Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritisM Bonelli, E Ferner, L Göschl, et al.
Pageof 147